- ... et al.: Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial ... Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma. J Clin Oncol 33 (24): 2617-22, 2015. [ ...
- ... treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: a comparison limited to patients ... treatment outcomes of radiotherapy and surgery in locally advanced carcinoma of the larynx: a comparison limited to patients ...
- ... Ricci S, Mazzaferro V, et al.: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359 (4): 378-90, ... Ricci S, Mazzaferro V, et al.: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359 (4): 378-90, ...
- ... al. (2002) Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? Cancer 95(8): 1685–1695 [ PubMed : 12365016 ] Ueno ...
- ... either metastatic colorectal carcinoma [ 15 , 22 ] or locally advanced colorectal carcinoma.[ 16 ] The trial that involved patients with metastatic ... phase II trial that involved patients with locally advanced colorectal carcinoma (i.e., large tumors and no regional lymph ...
- ... doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma. Cancer 56 (9): 2155-60, 1985. [ PubMed : 3902203 ] ... doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma. Cancer 56 (9): 2155-60, 1985. [ PubMed : 3902203 ] ...
- ... that the PRS effectively discriminated between risk for advanced neoplasms (carcinoma or advanced adenomas) versus nonadvanced adenomas and normal colonoscopic findings. ...
- ... NB, et al.: Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option. Br J Cancer 111 ( ... Ib KEYNOTE-028 ( NCT02054806 ) trial for patients with advanced tumors with ... squamous cell carcinoma.[ 5 ] The overall response rate was 17%, and ...
- ... and erlotinib (100 mg/d) in patients with advanced or metastatic pancreatic carcinomas.[ 9 ][ Level of evidence: 1iiA ] The addition of ... and erlotinib (100 mg/d) in patients with advanced or metastatic pancreatic carcinomas.[ 6 ][ Level of evidence: 1iiA ] The addition of ...
- ... Cetuximab plus radiotherapy for the treatment of locally advanced squamous cell carcinoma of the head and neck. Health technology assessment ( ...
31 results